期刊文献+

大鼠脂肪来源干细胞抵抗人血清介导的异种体液免疫杀伤作用及其机制 被引量:1

Resistance of rat adipose-derived stem cells to human xenoantibody-dependant complement-mediated lysis and its mechanism
原文传递
导出
摘要 目的研究大鼠脂肪来源干细胞(rASC)抵抗人血清介导的异种体液性杀伤的作用及其主要机制。方法分离培养SD大鼠ASC,将2~8代的rASC作为实验材料,以大鼠淋巴细胞(rLC)作为对照。采用流式细胞技术,检测两种细胞异种抗原”Gal的表达情况,体积分数20%正常人血清对两种细胞的杀伤作用、两种细胞分别与正常人血清中天然抗体IgM和IgG的结合情况,以及与正常人血清作用后补体C3c、CAc,CSb-9在两种细胞上的沉积情况。结果成功分离和培养rASC,rASC表面标志检测呈CD44阳性、CD45阴性、CD90阳性及主要组织相容性抗原Ⅱ阴性,并成功诱导rASC向成脂细胞和成骨细胞分化。相对于rLC,rASC对人血清介导的异种体液性杀伤具有明显的抵抗作用,其几何平均荧光强度(Gmean)值为(20.42±2.80)%,低于rLC的(51.84±6.70)Vo(P〈0.01);rASC上α-Gal的表达量为13.97±0.33,显著低于rLC的24.47±3.03(P〈0.05);rASC与人血清中IgG和IgM的结合量分别为9.4±2.0和5.73±1.0,显著低于rLC的107.2±4.8和27.49±3.9(P〈0.01);与正常人血清作用后,rLC可见显著的C3c、CAc和C5b-9沉积(Gmean值分别为1924±509.4、177.3±37.17和37.05±7.4),但rASC仅有较少C3c和CAc沉积(Gmean值分别为294.6±38.02和35.23±3.1),C5b-9沉积几乎为阴性(Gmean值为5.63±1.74),两种细胞间比较,差异均有统计学意义(P〈0.05或P〈0.01)。结论rASC能明显抵抗人血清介导的异种体液免疫杀伤作用,其机制可能与rASC低表达异种抗原α-Gal及抑制了补体攻膜复合物形成有关。 Objective To investigate whether rat adipose-derived stem cells (rASCs) could resist human xenoantibody-dependent complement-mediated lysis and to explore its possible mechanisms. Method SD rat ASCs were isolated, rASCs at passage 2 to 8 were used for the following studies and rat lymphocytes were harvested as control cells, α-Gal expression was detected by flow cytometry. After incubation of rASCs with 20% normal human serum (NHS) or heat inactivated normal human serum (HINHS), flow cytometry was used to detect cytotoxicity, IgG or IgM binding, and C3c, CAc and C5b-9 deposition. Result We successfully established the method to isolate and culture rASCs. The morphology of rASCs remained unchanged after passages, rASCs were positive for tell surface markers of CIN4 and CD90, while negative for CD45 and MHC-Ⅱ. As compared with rLCs, rASCs significantly resisted human natural antibody and complement-mediated lysis when incubated with 20% NHS in vitro (20.42± 2.80% vs 51.84% ± 6.70%, P〈 0.01). Mechanistieally, rASCs expressed lower level of α-Gal (13.97 ±0. 33 vs. 24. 47 ± 3.03, P〈0. 05), which was correlated with decreased binding of human xenoreactive IgG and IgM (IgM.. 9. 4 ± 2. 0 vs. 107.2± 4. 8, P〈0.01; IGG:5.73 ± 1.0 vs. 27. 49 ± 3.9, P〈0.01) and reduced deposition of complements C3c, CAc and C5b-9 (C3c: 294. 6 ± 38. 02 vs. 1924 ± 509. 4, P〈 0. 05; CAc.. 35.23 ± 3. 1 vs. 177.3±37.17,P〈0.05; C5b-9 : 5. 63 ±1. 74 vs. 37. 05± 7. 4 , P〈0. 01). Conclusion Thesedata demonstrated that the resistance of rASCs to human xenoantibody and complemenvmediated lysis is associated with low expression of xenoantigen α-Gal and inhibition of MAC (membrane attack complex) formation.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2014年第6期370-373,共4页 Chinese Journal of Organ Transplantation
关键词 脂肪干细胞 体液免疫 异种抗原 Adipose-derived stem cell Humoral immunity Xenoantigen
  • 相关文献

参考文献15

  • 1Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells[J]. Mol Biol Cell, 2002, 13 (12) :4279-4295.
  • 2Planat-B nard V, Menard C, Andr M, et al. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells [J]. Circ Res,2004,94(2) :223-229.
  • 3Banas A, Teratani T, Yamamoto Y, et al. Adipose tissue- derived mesenchymal stem cells as a source of human hepatocytes[J]. Hepatology, 2007,46 ( 1 ) : 219-228.
  • 4Timper K, Seboek D, Eherhardt M, et al. Human adipose tissue-derived mesenehymal stem cells differentiate into insulin, somatostatin, and glueagon expressing cells [J]. Biochem Biophys Res Commun, 2006,341 (4) : 1135-1140.
  • 5Schaffler A, B chler C. Concise review: adipose tissue-derived stromal cells--basic and clinical implications for novel cell-based therapies[J]. Stem Cells, 2007,25 (4) : 818-827.
  • 6Puissant B, Barreau C, Bourin P, et al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells[J]. Br J Haematol, 2005,129(1) : 118-129.
  • 7De Ugarte DA, Morizono K, Elbarbary A, et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow [J]. Cells Tissues Organs, 2003,174(3) : 101-109.
  • 8Gomillion CT, Burg KJ. Stem cells and adipose tissue engineering[J]. Biomaterials, 2006,27 (36) : 6052-6063.
  • 9Sajjadian A, Tandav Magge K. Treating facial soft tissue deficiency: fat grafting and adipose-derived stem cell tissue engineering[J]. Aesthet Surg J, 2007,27 (1) : 100-104.
  • 10Crop MJ,Baan CC,Korevaar SS, et al. Human adipose tissue- derived mesenchymal stem cells induce explosive T-cell proliferation[J]. Stem Cells Dev,2010,19(12):1843-1853.

同被引文献2

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部